DAXXIFY

daxibotulinumtoxinA-lanm · Revance Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for DAXXIFY, covering 2014-05-07 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial Spasm [Phase 4]